Utility of beta-lactam allergy assessment in patients receiving vancomycin for surgical prophylaxis

Kendall J Tucker1, YoungYoon Ham2, Haley K Holmer3

  • 1Department of Pharmacy Practice, College of Pharmacy, Oregon State University, United States.

PubMed
Abstract

Insights

Patients with beta-lactam allergies often receive vancomycin for surgical prophylaxis, but many are eligible for first-line beta-lactam antibiotics. Improved allergy assessment can optimize antimicrobial stewardship.

Area of Science:

  • Infectious Diseases
  • Clinical Pharmacy
  • Surgical Prophylaxis

Background:

  • Beta-lactam antibiotics are standard for surgical prophylaxis.
  • Patients with reported beta-lactam allergies often receive vancomycin, despite low cross-reactivity with penicillins and cephalosporins.
  • This practice aims to prevent allergic reactions.

Purpose of the Study:

  • To evaluate adult patients receiving vancomycin for surgical prophylaxis due to reported beta-lactam allergy.
  • To determine their eligibility for penicillin allergy testing or standard beta-lactam prophylaxis.
  • To identify opportunities for antimicrobial stewardship interventions.

Main Methods:

  • Retrospective evaluation of adult patients from August 2017 to July 2018.
  • Inclusion criteria: vancomycin for surgical prophylaxis with a reported beta-lactam allergy.
  • Analysis of eligibility for beta-lactam prophylaxis or allergy testing.

Main Results:

  • 830 patients received vancomycin; 196 reported beta-lactam allergy.
  • Orthopedic surgeries accounted for approximately 40% of cases.
  • 189 (96.4%) of patients receiving vancomycin as first-line therapy were eligible for beta-lactam prophylaxis.

Conclusions:

  • Many patients with beta-lactam allergies are suitable candidates for first-line antibiotic prophylaxis.
  • Enhanced allergy assessment is crucial for effective antimicrobial stewardship in surgical settings.
  • Optimizing antibiotic selection can improve patient care and reduce unnecessary vancomycin use.